Current findings using rat hearts have implied that the cardioprotective effect induced by urocortin‐1 is mediated by activation of Epac2 (Calderon‐Sanchez et al.,2016) and that Epac2 inhibition promotes cardiac arrhythmias (Yang et al.,2016). This evidence concerns the gene RAPGEF4 and chronic obstructive pulmonary disease.